The NASA Life Sciences Portal (NLSP) is the data platform for accessing NASA's Life Sciences Data Archive (LSDA). The LSDA is an active archive that provides information and data from 1961 (Mercury Project) through current flight and flight analog studies (International Space Station, Shuttle, bed rest studies, etc.) involving human, plant and animal subjects. Alternative contact: Jessica Keune (jessica.a.keune@nasa.gov)

Comprehensive life sciences data collection covering SAR, ADME data, toxicity values, bioactivity observations, pharmacological data, nucleic acid and protein sequences, molecular biomarkers, metabolic signaling pathways, and antibody-related proteins.

The Life Science Tools Market Report is Segmented by Type (Instruments, Consumables, and Services), Technology (PCR & QPCR, Sanger Sequencing, Separation Technologies, and More), Application (Proteomics Technology, Genomic Technology, and More), End User (Research Laboratories, Diagnostic Laboratories, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

snapshot-tab-pane Life Science Software Market Size 2025-2029The life science software market size is forecast to increase by USD 5.69 billion, at a CAGR of 9.7% between 2024 and 2029.The market is experiencing significant growth, driven by the increasing emphasis on managing and storing vast amounts of patient data. This trend is particularly pronounced in the context of precision medicine, which relies on comprehensive patient data to deliver personalized treatments. However, this data-centric approach presents challenges, as the life sciences industry grapples with heightened security and privacy concerns. Ensuring the protection of sensitive patient information is a critical priority, necessitating robust data security measures and adherence to stringent regulatory standards.These dynamics underscore the importance of investing in advanced life science software solutions that can effectively manage and secure large volumes of data, while enabling the delivery of precision medicine treatments. Companies that can successfully navigate these challenges and capitalize on the opportunities presented by the growing focus on patient data will be well-positioned to thrive in this dynamic market.What will be the Size of the Life Science Software Market during the forecast period?Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report. Request Free SampleThe market is characterized by its continuous evolution and dynamic nature, with ongoing advancements shaping the industry landscape. This market encompasses a range of applications, including agile development for research projects, biomarker discovery through data analysis, and research data management for genomics and proteomics research. Deep learning models and bioinformatics software play a pivotal role in this sector, enabling the processing and interpretation of vast amounts of scientific data. Technical support and software development ensure seamless integration of these tools, while machine learning algorithms and data visualization enhance their capabilities. Cloud-based software solutions, such as software-as-a-service (SaaS) and scientific data management systems, facilitate accessibility and collaboration among researchers and teams.Clinical trial management, training and consulting, and regulatory affairs are also critical components of the market, ensuring compliance and efficiency in drug discovery and development processes. The integration of various tools, including chromatography data systems, spectroscopy data analysis, and automated workflow management, further enriches the life science software ecosystem. API integrations and software maintenance ensure compatibility and reliability, while user experience (UX) and user interface (UI) design optimize the interaction between researchers and software platforms. Computational biology, high-throughput screening, and molecular modeling are further applications that contribute to the ongoing advancements in the market, underscoring its importance in driving innovation and discovery in the scientific community.How is this Life Science Software Industry segmented?The life science software industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. End-userPharmaceuticalBiotechnologyOthersDeploymentCloud-basedOn-premisesApplicationPreclinical and clinical trialsSupply chain managementResearch and developmentCommercial engagement and brandingOthersGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKAPACChinaIndiaJapanSouth KoreaRest of World (ROW). By End-user InsightsThe pharmaceutical segment is estimated to witness significant growth during the forecast period.Life science software plays a pivotal role in the pharmaceutical sector, providing a standardized healthcare infrastructure that complements existing Enterprise Resource Planning (ERP) systems. This software enhances logistics partnerships and facilitates collaboration with contract packagers. It also boosts company visibility, supports analytics, and offers risk management solutions. Throughout the product lifecycle, life science software expedites clinical trial management, product and project delivery, and regulatory compliance. It fosters innovative product development through collaborative efforts and enables personalized medicine through advanced analytics of clinical, sensor, and Big Data. Life science software solutions encompass various applications, such as machine learning algorithms for drug discovery, bioinformatics software for genomics research, and chromatography data systems for proteomics research.Cl

Life Science Analytics Market size was valued at USD 31.82 Billion in 2024 and is projected to reach USD 85.18 Billion by 2032, growing at a CAGR of 13.10% from 2026 to 2032.Growing Volume of Healthcare Data: The exponential increase in data generated from sources like electronic health records (EHRs), clinical trials, wearable devices, and genomic research is a primary driver of the life science analytics market. As pharmaceutical, biotech, and research organizations collect vast amounts of information, traditional data management systems are becoming obsolete. Analytics solutions are now essential for processing, integrating, and deriving actionable insights from this complex data, enabling faster and more accurate research outcomes. This trend is particularly evident in North America and Europe, where well established digital health infrastructures are generating enormous datasets.

This statistic represents the global life science tool market as of April 2018, with a breakdown by segment. In April 2018, diagnostic and clinical supply life science tools accounted for around ** percent of the overall market.

The Life Science Cloud market is booming, projected to reach [estimated 2033 market size] by 2033 with a CAGR exceeding 15%! This comprehensive analysis explores market drivers, trends, restraints, key players (Salesforce, AWS, Veeva), and regional growth. Discover the future of cloud computing in healthcare, pharmaceuticals, and research.

This annual report includes charts on the UK life science sector, and how it compares to other countries. Areas covered include: UK industry research and development regulatory environment clinical research In March 2022, metric 3 was amended to “Industry spend on pharmaceutical research and development in the UK”. This edit reflects the inclusion of all spend on pharmaceutical research and development by all businesses, not only pharmaceutical companies.

The Life Science Analytics Market Report is Segmented by Product Type (Descriptive, Predictive, and Prescriptive Analytics), Component (Software Platforms and Services), Deployment Mode (On-Premise and Cloud-Based), Application (R&D, Pharmacovigilance, and More), End User (Pharma & Biotech, and More), and Geography (North America, Europe, and More). Market Forecasts are Provided in Terms of Value (USD).

The Times Higher Education World University Rankings by Subject 2026 reveal the world’s top universities for life sciences, including the best universities for biology, among other subjects. The 2026 Life Sciences ranking evaluates universities across four core disciplines: veterinary science, biological sciences (including biology and biochemistry), agriculture and forestry, and sport science.

The Life Science Tools market is booming, projected to reach $156.3 billion by 2033, driven by advancements in genomics, proteomics, and personalized medicine. Explore market trends, key players, and regional growth insights in this comprehensive analysis.

Alexandria Real Estate Equities owned the largest share of life science real estate in the United States in 2022. The Pasadena-headquartered real estate investment trust had about ** million square feet of life science real estate in its portfolio. This was over ***** times the amount of real estate owned by the second-largest owner of life science real estate, the New York-headquartered Blackstone BioMed. Among the top ten owners, only **** had over ** million square feet in their portfolios.

Life Science Products Market size is growing with a CAGR of 10.6% in prediction period and it crosses USD 7,869.7 Mn in 2032, from USD 3,887.5 Mn in 2025 .

The global life science tools market size was worth over USD 168.18 billion in 2025 and is poised to witness a CAGR of around 12.4%, crossing USD 541.3 billion revenue by 2035, driven by rising adoption of nanotechnology-based life science tools.

Financial overview and grant giving statistics of Life Science Washington

Life Science Reagents Market size was valued at USD 66.32 Billion in 2024 and is projected to reach USD 98.73 Billion by 2032, growing at a CAGR of 5.10% from 2026 to 2032.Life Science Reagents Market DriversRising Prevalence of Chronic and Infectious Diseases: The increasing incidence of chronic diseases like cancer, diabetes, and cardiovascular diseases, along with emerging infectious diseases, has driven the demand for diagnostic tests and research, boosting the use of life science reagents.Growth in Biotechnology and Pharmaceutical R&D: The expansion of biotechnology and pharmaceutical research and development, including drug discovery and development, has significantly increased the consumption of life science reagents for various assays and processes.Advancements in Genomics and Proteomics: Technological advancements in genomics, proteomics, and molecular biology, such as next-generation sequencing (NGS) and CRISPR gene editing, have accelerated the demand for specialized reagents used in research and clinical applications.Increasing Use of Reagents in Diagnostics: Life science reagents are essential in diagnostic testing, including immunoassays, PCR, and ELISA. The growing adoption of personalized medicine, companion diagnostics, and precision medicine is further fueling demand for reagents.

The global Life Science Analytics Market size is expected to reach USD 37.65 Billion in 2032 registering a CAGR of 12.7%. Our report provides a comprehensive overview of the industry, including key players, market share, growth opportunities and more.

Life Sciences Tools Market size was valued at USD 63.8 Billion in 2024 and is projected to reach USD 112.99 Billion by 2031, growing at a CAGR of 8.17% from 2026 to 2032.Global Life Sciences Tools Market DriversThe life sciences tools market is experiencing a significant surge, propelled by a combination of scientific breakthroughs, increased funding, and evolving healthcare needs. These tools, which include a wide array of instruments, reagents, and software, are essential for everything from basic research to the development of groundbreaking therapies. Understanding the key drivers behind this growth is crucial for anyone in the healthcare, biotechnology, or investment sectors. Here are the primary factors shaping this dynamic market.Key Drivers Fueling the Life Sciences Tools Market: The life sciences tools market is experiencing a significant surge, propelled by a combination of scientific breakthroughs, increased funding, and evolving healthcare needs. These tools, which include a wide array of instruments, reagents, and software, are essential for everything from basic research to the development of groundbreaking therapies. Understanding the key drivers behind this growth is crucial for anyone in the healthcare, biotechnology, or investment sectors. Here are the primary factors shaping this dynamic market.Increasing R&D Investment: A major catalyst for the life sciences tools market is the growing investment in research and development (R&D) by pharmaceutical and biotechnology companies, as well as academic and government institutions. This influx of capital is directly linked to the pursuit of new drugs, therapies, and diagnostic methods. As funding increases for cutting-edge fields like precision medicine, genomics, and proteomics, so does the demand for sophisticated tools and technologies that can support these complex research endeavors. This continuous cycle of investment and innovation creates a robust and expanding market for life sciences tools.Growth in Biopharmaceuticals, Biologics, and Gene & Cell Therapies: The escalating demand for biologics, biopharmaceuticals, and advanced gene and cell therapies is a powerful driver for the life sciences tools market. Unlike traditional small-molecule drugs, these therapies are derived from biological sources and require specialized tools, reagents, and instrumentation for their discovery, development, and manufacturing. The rise of biosimilars generic versions of biologics further fuels this demand by necessitating high-quality, consistent, and regulatory-compliant tools to ensure product equivalence and safety. This segment's rapid growth is creating a sustained need for a diverse range of specialized life sciences tools.Technological Advances: The market is being transformed by a wave of technological innovations. The widespread adoption of next-generation sequencing (NGS), high-throughput screening (HTS), and single-cell analysis is enabling researchers to explore biological systems with unprecedented speed and detail. In addition, new technologies like CRISPR/gene editing and synthetic biology are revolutionizing genetic research. The integration of digital technologies, such as artificial intelligence (AI) and machine learning (ML), is also playing a pivotal role. These tools are used for complex data analysis, lab automation, and bioinformatics, enhancing the efficiency and scale of scientific discovery.Demand for Precision: The shift toward precision medicine is fundamentally reshaping healthcare and, by extension, the life sciences tools market. This approach focuses on tailoring medical treatments to individual patients based on their unique genetic, environmental, and lifestyle profiles. The growing emphasis on biomarker discovery and genetic and molecular diagnostics is creating a strong need for tools that can perform detailed genetic profiling, analyze complex biological data, and identify specific disease markers. As personalized therapies become more common, the demand for sophisticated diagnostic and research tools will continue to rise.

State of the Life Sciences Industry Market Report delivers insights on biotech, pharma, medical devices, innovation trends, and global market outlook.

Explore the 2025 Times Higher Education Subject Rankings for Life Sciences.